High-mobility group box 1 exacerbates CCl₄-induced acute liver injury in mice

Copyright © 2014 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 153(2014), 1 vom: 15. Juli, Seite 56-63
Auteur principal: Chen, Maojian (Auteur)
Autres auteurs: Huang, Wenjian, Wang, Chao, Nie, Hao, Li, Gang, Sun, Ting, Yang, Fei, Zhang, Yanxiang, Shu, Kegang, Wang, Congyi, Gong, Quan
Format: Article en ligne
Langue:English
Publié: 2014
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Acute liver injury Carbon tetrachloride HMGB1 Lipid peroxidation Antibodies, Blocking Antibodies, Monoclonal HMGB1 Protein Interleukin-6 plus... Recombinant Proteins Tumor Necrosis Factor-alpha Carbon Tetrachloride CL2T97X0V0
LEADER 01000caa a22002652 4500
001 NLM237311445
003 DE-627
005 20250216220513.0
007 cr uuu---uuuuu
008 231224s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2014.03.021  |2 doi 
028 5 2 |a pubmed25n0791.xml 
035 |a (DE-627)NLM237311445 
035 |a (NLM)24726765 
035 |a (PII)S1521-6616(14)00085-0 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Chen, Maojian  |e verfasserin  |4 aut 
245 1 0 |a High-mobility group box 1 exacerbates CCl₄-induced acute liver injury in mice 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 12.09.2014 
500 |a Date Revised 25.11.2016 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2014 Elsevier Inc. All rights reserved. 
520 |a High-mobility group box 1 (HMGB1) is a nuclear factor that can also serve as an imflammatory mediator once released into extracellular milieu. Therefore, HMGB1 has been recognized to play a pivotal role in inflammatory diseases such as sepsis, acute lung injury, ischemia reperfusion injury and type 1 diabetes. Nevertheless, its impact on carbon tetrachloride (CCl4)-induced hepatic injury is yet to be elucidated. In the present report, we demonstrated evidence indicating that high levels of HMGB1 were not only present in the necrotic area of liver but also in the serum after CCl4 challenge. In line with these observations, administration of exogenous recombinant HMGB1 exacerbated CCl4-induced hepatic injury, while HMGB1 blocking antibody provided protection for mice against CCl4-induced acute liver injury as evidenced by the decrease of serum transaminase and reduction of hepatic tissues necrosis. Mechanistic studies revealed that blockade of HMGB1 attenuated CCl4-induced MDA accumulation along with improved SOD and GSH activity. Treatment of mice with HMGB1 neutralizing antibody also significantly inhibited the production of proinflammatory mediators TNF-α and IL-6 along with attenuated HMGB1 expression and its extracellular release. Together, our data suggest an essential role for HMGB1 in CCl4-induced acute liver injury, while HMGB1 neutralizing antibody could be served as an effective regimen for preventing CCl4-induced acute liver injury 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Acute liver injury 
650 4 |a Carbon tetrachloride 
650 4 |a HMGB1 
650 4 |a Lipid peroxidation 
650 7 |a Antibodies, Blocking  |2 NLM 
650 7 |a Antibodies, Monoclonal  |2 NLM 
650 7 |a HMGB1 Protein  |2 NLM 
650 7 |a Interleukin-6  |2 NLM 
650 7 |a Recombinant Proteins  |2 NLM 
650 7 |a Tumor Necrosis Factor-alpha  |2 NLM 
650 7 |a Carbon Tetrachloride  |2 NLM 
650 7 |a CL2T97X0V0  |2 NLM 
700 1 |a Huang, Wenjian  |e verfasserin  |4 aut 
700 1 |a Wang, Chao  |e verfasserin  |4 aut 
700 1 |a Nie, Hao  |e verfasserin  |4 aut 
700 1 |a Li, Gang  |e verfasserin  |4 aut 
700 1 |a Sun, Ting  |e verfasserin  |4 aut 
700 1 |a Yang, Fei  |e verfasserin  |4 aut 
700 1 |a Zhang, Yanxiang  |e verfasserin  |4 aut 
700 1 |a Shu, Kegang  |e verfasserin  |4 aut 
700 1 |a Wang, Congyi  |e verfasserin  |4 aut 
700 1 |a Gong, Quan  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 153(2014), 1 vom: 15. Juli, Seite 56-63  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:153  |g year:2014  |g number:1  |g day:15  |g month:07  |g pages:56-63 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2014.03.021  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 153  |j 2014  |e 1  |b 15  |c 07  |h 56-63